Cite

HARVARD Citation

    Gu, L. et al. (2020). Magnitude of benefit of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for malignant tumor: A meta-analysis. Critical reviews in oncology/hematology. p. . [Online]. 
  
Back to record